Pramlintide
Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 636
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.